AVEO PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
AVEO PHARMACEUTICALS, INC. has filed 1,019 SEC EDGAR filings since 27 Apr 2005

SEC filing history

Showing 651-675 of 1,000 matching filings.

Per page
25
Current page
27
8-K File 001-34655

8-K

Filing date
02 Dec 2013
Reporting date
26 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85745

DISCLOSURE DOCUMENT

Filing date
08 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MICHAEL BAILEY FORM 4

Filing date
04 Oct 2013
Reporting date
02 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

GYURIS FORM 4

Filing date
04 Oct 2013
Reporting date
02 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

HA-NGOC FORM 4

Filing date
04 Oct 2013
Reporting date
02 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

JOHNSTON FORM 4

Filing date
04 Oct 2013
Reporting date
02 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SLICHENMYER FORM 4

Filing date
04 Oct 2013
Reporting date
02 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

VITTIGLIO FORM 4

Filing date
04 Oct 2013
Reporting date
02 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Oct 2013
Reporting date
01 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

TERMEER FORM 4

Filing date
03 Oct 2013
Reporting date
01 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

YOUNG FORM 4

Filing date
03 Oct 2013
Reporting date
01 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34655

FORM 8-K

Filing date
25 Jul 2013
Reporting date
24 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34655

FORM 8-K

Filing date
11 Jul 2013
Reporting date
03 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85745

SC 13G filing

Filing date
10 Jul 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Jul 2013
Reporting date
01 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

TERMEER FORM 4

Filing date
02 Jul 2013
Reporting date
01 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

WEG FORM 4

Filing date
02 Jul 2013
Reporting date
01 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

YOUNG FORM 4

Filing date
02 Jul 2013
Reporting date
01 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MICHAEL BAILEY FORM 4

Filing date
26 Jun 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

GYURIS FORM 4

Filing date
26 Jun 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

JOHNSTON FORM 4

Filing date
26 Jun 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SLICHENMYER FORM 4

Filing date
26 Jun 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

VITTIGLIO FORM 4

Filing date
26 Jun 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .